Zydus Cadila receives US FDA approval for Risperidone tablets (PharmaBiz)
Zydus Cadila has received an approval from the US FDA to market Risperidone Tablets 0.25, 0.05, 1, 2, 3, and 4 mg. Risperidone falls in the CNS segment and the estimated sales as per NDC was US$ 2.1 billion in 2007.

HHS Preparing To Open FDA Offices In China, India, Europe, And Latin America This Year (Medical News Today)
The U.S. Department of Health and Human Services will send the first U.S. Food and Drug Administration (FDA) staff to China, India, Europe, and Latin America before the end of 2008, HHS Secretary Mike Leavitt announced today. "We're making steady progress to better safeguard our supply of food and medicines, though much work remains," Secretary Leavitt said.